When patients look to you for answers, look to us for insights.

Solving today’s most complex health challenges starts with putting the right data insights in the hands of the right people. At Memorial Sloan Kettering Cancer Center (MSK), we are leading the field of specialty oncology data and insights.

MSK’s robust data combines de-identified longitudinal clinical information and genomic
data from MSK’s comprehensive genomic profiling tests for both solid tumors and
hematologic malignancies.  Data covers all prevalent cancer types, as well as rare cancers.  Clinically relevant and actionable biomarkers are represented among the datasets.

Learn more about Clinical-Genomic data licensing opportunities at MSK, where our record of global regulatory approval includes 15 therapies that originated in MSK laboratories.

Licensing Opportunities

For more information, please contact MSK’s Digital Health - Business Development & Licensing team at [email protected] .